Hepatic dysfunction in preeclampsia: association with high levels of gammaglutamyltransferase

Authors

  • Jorge Mario Gómez Jiménez
  • Jhon Jairo Zuleta Tobón
  • Germán Campuzano Maya
  • José Cantillo Pabón

DOI:

https://doi.org/10.18597/rcog.647

Keywords:

Preeclampsia, gammaglutamyltransferase, Hellp, enzyme

Abstract

Objective: To explore the relationships between elevated serum level of gammaglutamyltransferase (eGGT) and preeclampsia (PE) and related complications before 35 weeks of gestational age.

Methodology: Cross sectional study.

Population and source: 109 pregnant patients before 35 weeks of gestational age [Group I (G I) n = 55 pre-eclamptic patients and group II (G II) n = 54 non pre-eclamptic patients] of the hospitals Universitario San Vicente de Paúl and General de Medellín, between September 1st,1999 and September 1st, 2000.

Background: Association between eGGT and PE.

Statistical analysis: Kolmogorov-Smirnov´s test to evaluate normality, Spearman´s Rho to continuous variables; Mann-Witney's U test to compare the medians, Relationships by Odds Ratios.

Results: There were no differences between both groups when analyzing general characteristics. There was no association between eGGT and pregnant age, gestational age nor parity (Spearman´s rho - 0.03, 0.08 and 0.137 respectively).

The medians of gammaglutamyltransferase levels (mGGT) were 22.62 UI/L (range 4.76-142.79) and 17.63 (range 7.22 - 77.86) on G I and G II patients, respectively (p = 0.81, Mann-Witney's U test).

Eleven pre-eclamptic pregnant women in G I (20%) had eGGT [arbitrare cutoff > 49.0525 U/L, mayor or equal than percentile 95 (95p) of the controls] in front to 2 non pre-eclamptic women (3.7%) in G II (p = 0.009), odds ratio (OR) 6.5; 95% confidence interval (CI) 1.25-45.02.

Fourteen patients in G I had complications attributable to PE, five resulted positive for eGGT in front to 6 positive women of 41 without complications in same group (p = 0.12).

Of twenty-five intrauterine growth restriction (IUGR) events in G I, eight resulted positive for eGGT compared to three with eGGT of 30 in the same group which did not exhibit IUGR (p = 0.088). There were six IUGR events in 26 G II negative for eGGT patients that ended its gestation at the source hospitals.

Conclusion: eGGT level in pregnancy was defined > p95, like a concentration > 49,0525 UI/L and evidence of an association, though not causal, with severe PE was found.

Author Biographies

Jorge Mario Gómez Jiménez

Ginecoobstetra, docente Universidad de Antioquia.

Jhon Jairo Zuleta Tobón

Ginecoobstetra, docente Universidad de Antioquia.

Germán Campuzano Maya

Hematólogo clínico, Laboratorio Clínico Hematológico.

José Cantillo Pabón

Residente II de Ginecoobstetricia, Universidad de Antioquia

References

Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribean. Br J Obstet Gynaecol 1992;99:547-52.

Berg CJ, Atrash HK, Koonin LM, Tucker M. Pregnancy -related mortality in the United States, 1987-1990. Obstet Gynecol 1996;88:161-7.

Presidencia de la República, Departamento Nacional de Planeación, Ministerio de Salud y otros. Mortalidad Materna en Colombia. Santafé de Bogotá, agosto 1996.

Sibai B, Mencer B, Sarinoglu C. Severe preeclampsia in the second trimester: Recurrence Risk and long-term prognosis. Am J Obstet Gynecol 1991;165:1408-12.

Ness R, Roberts JM. Heterogeneous causes constituting the single syndrome of Preeclampsia: A hypothesis and its implications. Am j Obstet Gynecol 1996;175:1365-70.

Stone JL, Lockwood CHJ, Berkowitz GS. Risk Factors for Severe Preeclampsia. Obstet and Gynecol 1994;83:357-61.

Sibai B. Aspectos inmunitarios de la PE. Clin Obstet y Ginecol 1991;1:27-33.

Churchill D, Kilby MD, Bignell A, et al. Gamma-glutamyl transferase activity in gestational hypertension. Br J Obstet Gynaecol 1994;101:251-3.

Wetmore LA, Gerard C, Drazen JM. Human lung expresses unique gamma-glutamyl transpeptidase transcripts. Proc Natl Acad Sci USA 1993;15(90):7461-5.

Bacq Y, Zarka O, Brechot JF y cols. Liver function test in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996;23:1030-4.

Girling JC, Dow E, Smith JH. Liver function test in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 1997;10:246-50.

Liu J. Clinical significance of serum AKP, HSAP, LAP and gamma-GT determination in high-risk pregnancy. Chung Hua Fu Chan Ko Tsa Chih 1989;2:66-9.

How to Cite

1.
Gómez Jiménez JM, Zuleta Tobón JJ, Campuzano Maya G, Cantillo Pabón J. Hepatic dysfunction in preeclampsia: association with high levels of gammaglutamyltransferase. Rev. colomb. obstet. ginecol. [Internet]. 2002 Jun. 28 [cited 2024 May 13];53(2):171-7. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/647

Downloads

Download data is not yet available.

Published

2002-06-28

Issue

Section

Original Research
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo

Some similar items: